Dicarboxylic acids and derivatives
Medchemexpress LLC BNC-101 10mg | 10mg
BNC-101 is a human-derived antibody expressed in CHO cells that targets GPR49/LGR5 The predicted molecular weight (MW) of BNC-101 is 150 kDa The isotype control for BNC-101 can refer to Human IgG1 kappa Isotype Control (HY-P99001)
Medchemexpress LLC UK-101 | 1000313-40-5 | 99.6% | 484.74 g/mol | 50 MG
UK-101 is a potent, selective inhibitor of the immunoproteasome β1i (LMP2) subunit, commonly used in proteasome biology and cancer research to study apoptosis and proteasome-mediated pathways.
- Potent LMP2 inhibition with an IC50 of about 104 nM.
- Demonstrates high selectivity versus related proteasome subunits for target-specific studies.
- Induces cell apoptosis, useful in cancer biology assays.
- High purity (≈99.6%) for reproducible experimental results.
- Soluble in DMSO (≈7.3 mg/mL) for easy stock preparation.
- Stable as a powder under low-temperature storage for long-term use.
- Provided in a small research pack suitable for laboratory assays.
Medchemexpress LLC Pigment Yellow 101 | 2387-03-3 | 98.1% | 100 MG
Pigment Yellow 101 is a yellow bis-azomethine pigment that exhibits solid-state fluorescence and is available as a commercial colorant.
- Exhibits solid-state fluorescence
- Available as a commercial colorant
- Yellow bis-azomethine pigment
- Excitation/emission: 411 nm/512 nm
Medchemexpress LLC AVN-101 hydrochlorid 5mg | 1061354-48-0 | 340.89 g/mol | C21H25ClN2 | 5 MG
AVN-101 hydrochloride is a brain-penetrant, orally active 5-HT7 receptor antagonist used in pharmacological research. Supplied as a 5 mg powder with high purity, it is suitable for in vitro assays and preclinical studies requiring selective serotonergic modulation.
- High purity suitable for research applications.
- Brain-penetrant profile for central nervous system studies.
- Orally active salt form compatible with dosing studies.
- Stable powder for sealed, low-temperature storage.
- Small packaging appropriate for early-stage research.
Medchemexpress LLC Lauroyl-L-carnitine (chloride) | 6919-91-1 | MFCD00274131 | 98.1% | 379.96 g·mol⁻¹ | C19H38ClNO4 | 5 MG
Lauroyl-L-carnitine chloride is an acylcarnitine-derived absorption enhancer used in research to increase the oral bioavailability of peptide compounds. It is provided as a high-purity solid for laboratory use and can be prepared as solutions for experimental assays following recommended storage conditions.
- Orally active absorption enhancer for peptide compounds.
- Improves oral bioavailability of peptide therapeutics in preclinical studies.
- Supplied as a high-purity solid suitable for solution preparation.
- Available in small research pack sizes and larger quantities on request.
- Stable when stored sealed at 4°C; in solution store at -80°C (6 months) or -20°C (1 month).
- Molecular formula C19H38ClNO4; molecular weight 379.96 g·mol⁻¹.
![Medchemexpress LLC 7-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxyheptanamide | 1012054-59-9 | MFCD15528940 | >98.0% | 434.49 g/mol | C24H26N4O4 | 100 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000247159.png-250.jpg)
Medchemexpress LLC 7-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxyheptanamide | 1012054-59-9 | MFCD15528940 | >98.0% | 434.49 g/mol | C24H26N4O4 | 100 MG
CUDC-101 is a small-molecule research compound that concurrently inhibits histone deacetylases (HDACs) and receptor tyrosine kinases EGFR and HER2. It is used in preclinical cancer research to study combined epigenetic and kinase-targeted therapies.
- Potent inhibition of HDAC, EGFR, and HER2 with IC50s of 4.4 nM, 2.4 nM, and 15.7 nM.
- Contains a hydroxamic acid moiety associated with HDAC activity.
- High purity (>98.0%) suitable for research applications.
- Soluble in DMSO at 25 mg/mL (approximately 57.54 mM; may require ultrasonic agitation).
- Molecular formula C24H26N4O4 and molecular weight 434.49 g/mol.
Medchemexpress LLC Lauroyl-L-carnitine-d3 hydrochloride | 1297271-52-3 | C₁₉H₃₅D₃ClNO₄ | 2.5 MG
Lauroyl-L-carnitine-d3 (hydrochloride) is a deuterium labeled compound. Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs.
- Deuterium labeled compound
- Used as tracers for quantitation during drug development
- Potential to affect pharmacokinetic and metabolic profiles of drugs
- For research use only
Medchemexpress LLC BNC-101 5mg | 5mg
BNC-101 is a human-derived antibody expressed in CHO cells that targets GPR49/LGR5 The predicted molecular weight (MW) of BNC-101 is 150 kDa The isotype control for BNC-101 can refer to Human IgG1 kappa Isotype Control (HY-P99001)
